Cargando…

A pancreatic mass and extreme elevation of CA 19–9: a benign masquerade of cholangiocarcinoma

Carbohydrate antigen 19–9 (CA 19–9) is a specific tumour marker for pancreato-biliary malignancy. Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition in which IgG4 deposits infiltrate various organs, including the biliary tract manifesting IgG4 sclerosing cholangitis and pseu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hall, Catherine, McLaren, Mairi, Mosse, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849326/ https://www.ncbi.nlm.nih.gov/pubmed/35186252 http://dx.doi.org/10.1093/jscr/rjac018

Ejemplares similares

The heart of the matter: secretory pheochromocytoma presenting as recurrent biventricular heart failure (Takotsubo cardiomyopathy)
por: Turner, Lauren M, et al.
Publicado: (2022)

Isolated pancreatic tuberculosis with elevated CA 19-9 levels masquerading as a malignancy: A rare case report and literature review
por: Sun, Pi-Jiang, et al.
Publicado: (2018)

Hepatic tuberculosis masquerading as cholangiocarcinoma: an unusual differential for a liver mass
por: Maguire, Christopher, et al.
Publicado: (2020)

Extraskeletal Ewing's Sarcoma Masquerading as Infantile Benign Neck Mass
por: Gazula, Suhasini, et al.
Publicado: (2019)

A case of Trousseau’s syndrome due to intrahepatic cholangiocarcinoma with an extremely high level of CA19-9
por: Sasaki, Ryosuke, et al.
Publicado: (2020)

Retroperitoneal Bronchogenic Cyst Mimicking a Pancreatic Cystic Lesion with Extremely High Level of Intralesional Fluid CA-19.9 Antigen: Benign in Disguise
por: Clementino-Filho, Jessé, et al.
Publicado: (2021)

Serum CA(19-9) in patients with solid pancreatic mass
por: Baghbanian, Mahmud, et al.
Publicado: (2013)

Benign Hydronephrosis and Elevated of Serum Levels of Carbohydrate Antigen CA 19-9: A Case Report
por: Filipovic, Branka, et al.
Publicado: (2016)

Mirizzi’s syndrome masquerading as cholangiocarcinoma: a case report
por: Khan, Muhammad Rizwan, et al.
Publicado: (2012)

Inflammatory myofibroblastic tumour of liver masquerading as hilar cholangiocarcinoma
por: Subash, R, et al.
Publicado: (2011)

A Rare Case of a Bladder Neck Abscess Masquerading as a Benign Mass
por: Abdullatif, Victor A., et al.
Publicado: (2022)

Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
por: Haglund, C., et al.
Publicado: (1989)

Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
por: Edwards, J G, et al.
Publicado: (2003)

A Rare Case of Aggressive Digital Adenocarcinoma of the Lower Extremity, Masquerading as an Ulcerative Lesion that Clinically Favored Benignancy
por: Vazales, Ryan, et al.
Publicado: (2014)

Common Hepatic Duct Mixed Adenoneuroendocrine Carcinoma Masquerading as Cholangiocarcinoma
por: Priyanka Akhilesh, Sali, et al.
Publicado: (2016)

Xanthogranulomatous Endometritis: A Benign Uncommon Masquerader of Malignancy
por: Malik, Vipra, et al.
Publicado: (2019)

Colonoscopic Appearances of an Appendiceal Remnant: The Benign Masquerading as the Sinister
por: Haboubi, Hasan N., et al.
Publicado: (2021)

Autoimmune pancreatitis masquerading as pancreatic cancer
por: Khanna K B, Jaydeesh, et al.
Publicado: (2021)

Combined Expression of Plasma Thrombospondin‐2 and CA19‐9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
por: Le Large, Tessa Y.S., et al.
Publicado: (2020)

Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
por: Haglund, C., et al.
Publicado: (1991)

Hepatic basidiobolomycosis masquerading as cholangiocarcinoma: a case report and literature review
por: Sehrawat, Roopali, et al.
Publicado: (2023)

Isolated mass-forming IgG4-related sclerosing cholangitis masquerading as extrahepatic cholangiocarcinoma: A case report
por: Song, Sanghyun, et al.
Publicado: (2021)

Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers
por: Yue, Tingting, et al.
Publicado: (2011)

Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors
por: Śmigielski, Jacek A., et al.
Publicado: (2013)

Pancreatic Dysfunction Masquerading as an Insulinoma
por: Shah, Siddharth, et al.
Publicado: (2023)

Colorectal Carcinoma with Extremely Low CA19-9
por: Kawamura, Yutaka J., et al.
Publicado: (2009)

Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma
por: Hu, Hai-Jie, et al.
Publicado: (2016)

Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma
por: Fang, Tianyi, et al.
Publicado: (2019)

The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.
por: Habib, N. A., et al.
Publicado: (1986)

Extreme elevation of CA 19-9 levels in mature cystic teratoma without any complications: A case report
por: Cho, Angela, et al.
Publicado: (2022)

Isolated pancreatic tuberculosis masquerading as pancreatic cancer
por: Zacharia, George S., et al.
Publicado: (2014)

Regressing basal-cell carcinoma masquerading as benign lichenoid keratosis
por: Kulberg, Aleksandra, et al.
Publicado: (2016)

Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia
por: Khanduri, Sachin, et al.
Publicado: (2019)

Carcinosarcoma of the Prostate Masquerading as Benign Prostatic Enlargement: Lesson Learned
por: Selvaraj, Nivash, et al.
Publicado: (2020)

Cavernous hemangioma with extensive sclerosis masquerading as intrahepatic cholangiocarcinoma — A pathologist's perspective
por: Andeen, Nicole K., et al.
Publicado: (2015)

P35 Lupus masquerading as Cholangiocarcinoma: One of the many faces of multifaceted lupus
por: Tarar, Bilal, et al.
Publicado: (2022)

CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2017)

Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma
por: Lee, Jong Woo, et al.
Publicado: (2021)

Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
por: Kim, Si-Young, et al.
Publicado: (2021)

Lymphoma Masquerading as an Ear Mass
por: Cuartas, Karen N, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_behpt1h1ghbqlmfc3djlah45sk